Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Receivables (2016 - 2019)

Fresenius Medical Care AG has reported Receivables over the past 11 years, most recently at $4.0 billion for Q4 2019.

  • Quarterly results put Receivables at $4.0 billion for Q4 2019, up 5.28% from a year ago — trailing twelve months through Dec 2019 was $4.0 billion (up 5.28% YoY), and the annual figure for FY2019 was $4.0 billion, up 5.28%.
  • Receivables for Q4 2019 was $4.0 billion at Fresenius Medical Care AG, up from $3.8 billion in the prior quarter.
  • Over the last five years, Receivables for FMCQF hit a ceiling of $4.6 billion in Q4 2017 and a floor of $3.5 billion in Q4 2015.
  • Median Receivables over the past 5 years was $4.0 billion (2019), compared with a mean of $4.1 billion.
  • Biggest five-year swings in Receivables: grew 28.89% in 2016 and later fell 17.46% in 2018.
  • Fresenius Medical Care AG's Receivables stood at $3.5 billion in 2015, then increased by 28.89% to $4.5 billion in 2016, then grew by 1.0% to $4.6 billion in 2017, then decreased by 17.46% to $3.8 billion in 2018, then rose by 5.28% to $4.0 billion in 2019.
  • The last three reported values for Receivables were $4.0 billion (Q4 2019), $3.8 billion (Q4 2018), and $4.6 billion (Q4 2017) per Business Quant data.